Aignostics
Berlin, DE · 5 known investors
Find your way into Aignostics
Sign up to see every warm intro you have to Aignostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aignostics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aignostics develops AI-powered pathology products and custom image and data analysis services for precision medicine and drug development, serving pharmaceutical and biomedical research teams. A spin-off from Charité Berlin, it works with academic and industry partners on tissue analysis validated by pathologists, from early drug discovery through regulated clinical applications.
Founders & leadership
Investors · 5
How we know: CARMA FUND's portfolio page · globenewswire.com · Not right? Tell us
How we know: globenewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: globenewswire.com · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Aignostics do?
- Aignostics develops AI-powered pathology products and custom image and data analysis services for precision medicine and drug development, serving pharmaceutical and biomedical research teams. A spin-off from Charité Berlin, it works with academic and industry partners on tissue analysis validated by pathologists, from early drug discovery through regulated clinical applications.
- Who are Aignostics's investors?
- Aignostics's investors include CARMA FUND, Boehringer Ingelheim Venture Fund, HTGF, IBB Ventures, Mayo Clinic Ventures.
- Where is Aignostics headquartered?
- Aignostics is headquartered in Berlin, DE.
